Synthesis, biological, and photophysical studies of molecular rotor-based fluorescent inhibitors of the trypanosome alternative oxidase.


Journal

European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510

Informations de publication

Date de publication:
05 Aug 2021
Historique:
received: 01 02 2021
revised: 26 03 2021
accepted: 10 04 2021
pubmed: 4 5 2021
medline: 24 8 2021
entrez: 3 5 2021
Statut: ppublish

Résumé

We have recently reported on the development and trypanocidal activity of a class of inhibitors of Trypanosome Alternative Oxidase (TAO) that are targeted to the mitochondrial matrix by coupling to lipophilic cations via C14 linkers to enable optimal interaction with the enzyme's active site. This strategy resulted in a much-enhanced anti-parasite effect, which we ascribed to the greater accumulation of the compound at the location of the target protein, i.e. the mitochondrion, but to date this localization has not been formally established. We therefore synthesized a series of fluorescent analogues to visualize accumulation and distribution within the cell. The fluorophore chosen, julolidine, has the remarkable extra feature of being able to function as a viscosity sensor and might thus additionally act as a probe of the cellular glycerol that is expected to be produced when TAO is inhibited. Two series of fluorescent inhibitor conjugates incorporating a cationic julolidine-based viscosity sensor were synthesized and their photophysical and biological properties were studied. These probes display a red emission, with a high signal-to-noise ratio (SNR), using both single- and two-photon excitation. Upon incubation with T. brucei and mammalian cells, the fluorescent inhibitors 1a and 2a were taken up selectively in the mitochondria as shown by live-cell imaging. Efficient partition of 1a in functional isolated (rat liver) mitochondria was estimated to 66 ± 20% of the total. The compounds inhibited recombinant TAO enzyme in the submicromolar (1a, 2c, 2d) to low nanomolar range (2a) and were effective against WT and multidrug-resistant trypanosome strains (B48, AQP1-3 KO) in the submicromolar range. Good selectivity (SI > 29) over mammalian HEK cells was observed. However, no viscosity-related shift could be detected, presumably because the glycerol was produced cytosolically, and released through aquaglyceroporins, whereas the probe was located, virtually exclusively, in the trypanosome's mitochondrion.

Identifiants

pubmed: 33940464
pii: S0223-5234(21)00319-6
doi: 10.1016/j.ejmech.2021.113470
pii:
doi:

Substances chimiques

Enzyme Inhibitors 0
Fluorescent Dyes 0
Mitochondrial Proteins 0
Plant Proteins 0
Oxidoreductases EC 1.-
alternative oxidase EC 1.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

113470

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Eduardo J Cueto-Díaz (EJ)

Instituto de Química Médica, IQM-CSIC, Juan de la Cierva 3, E-28006, Madrid, Spain.

Godwin U Ebiloma (GU)

Graduate School of Science and Technology, Department of Applied Biology, Kyoto Institute of Technology, Kyoto, 606-8585, Japan; Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom; School of Health and Life Sciences, Teesside University, Middlesbrough, United Kingdom.

Ibrahim A Alfayez (IA)

Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.

Marzuq A Ungogo (MA)

Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom; Department of Veterinary Pharmacology and Toxicology, Faculty of Veterinary Medicine, Ahmadu Bello University, Zaria, Nigeria.

Leandro Lemgruber (L)

Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.

M Carmen González-García (MC)

Departamento de Fisicoquimica, Facultad de Farmacia, Universidad de Granada, C. U. Cartuja, E-18071, Granada, Spain.

Maria D Giron (MD)

Departamento de Bioquimica y Biologia Molecular II. Facultad de Farmacia, Universidad de Granada, C. U. Cartuja, E-18071, Granada, Spain.

Rafael Salto (R)

Departamento de Bioquimica y Biologia Molecular II. Facultad de Farmacia, Universidad de Granada, C. U. Cartuja, E-18071, Granada, Spain.

Francisco José Fueyo-González (FJ)

Instituto de Química Médica, IQM-CSIC, Juan de la Cierva 3, E-28006, Madrid, Spain.

Tomoo Shiba (T)

Graduate School of Science and Technology, Department of Applied Biology, Kyoto Institute of Technology, Kyoto, 606-8585, Japan.

Juan A González-Vera (JA)

Departamento de Fisicoquimica, Facultad de Farmacia, Universidad de Granada, C. U. Cartuja, E-18071, Granada, Spain.

Maria José Ruedas Rama (MJ)

Departamento de Fisicoquimica, Facultad de Farmacia, Universidad de Granada, C. U. Cartuja, E-18071, Granada, Spain.

Angel Orte (A)

Departamento de Fisicoquimica, Facultad de Farmacia, Universidad de Granada, C. U. Cartuja, E-18071, Granada, Spain.

Harry P de Koning (HP)

Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.

Christophe Dardonville (C)

Instituto de Química Médica, IQM-CSIC, Juan de la Cierva 3, E-28006, Madrid, Spain. Electronic address: dardonville@iqm.csic.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH